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Abstract
Background: The ethanolic extract of the leaves of Ocimium gratisimum L. (Lamiaceae), used in
traditional medicine for the treatment of several ailments such as urinary tract, wound, skin and
gastrointestinal infections, was evaluated for its antibacterial properties against four clinical bacteria
isolates namely: Escherichia coli, Proteus mirabilis, Staphylococcus aureus and Pseudomonas aeruginosa
and the antifungal properties using a clinical isolate of Candida albicans. A typed bacterium of
Escherichia coli ATCC 11775 and another typed fungal strain of Candida albicans (ATCC 90028)
were also included. The study also intended to verify if the concomitant administration of
conventional antibiotics with Ocimium gratisimum which is normally taken as food (spice) will
negatively affect its activity.
Methods: The agar diffusion method was used to test the in vitro activity of the plant extract. The
interaction of the plant extract with some disc antibiotics namely: ciprofloxacin, septrin,
streptomycin, ampicillin, nystatin and ketoconazole was tested using the agar overlay inoculum
susceptibility disc method. Phytochemical analysis of the extract was performed following
established methods.
Results: The extract showed good but varying in vitro activities against all the isolates tested. While
ampicillin showed synergistic interaction with the plant extract against clinical isolates of E. coli and
P. mirabilis, septrin was synergistic against the clinical isolate of E. coli only. Similarly, the activity of
the extract against C. albicans isolate was synergistic with ketoconazole and nystatin.
Conclusion: The study has validated the folkloric use of O. gratissimum in traditional medicinal
practice and goes further to show that the use of this plant material as food spice may not really
threaten the efficacy of some conventional antibiotics that may have been taken concomitantly with
it as is the popular belief in the practice of herbal medicine in local/rural communities of many
countries in the world.
Background
The use of plant materials as spices, condiments and for
medicinal purposes dates back to the history of mankind
[1-3]. Recently, the exploitation of wild plants for medic-
inal purposes has gained more acceptances in many coun-
tries of the world. To further underscore the importance of
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herbal medicine, most national governments have estab-
lished the traditional medicine regulatory council under
the supervision of their various health ministries to tap
the numerous potentials of herbs. This may be because
traditional medicine has long been practiced even before
the orthodox medical practice appeared [4]. Ocimum
gratissimum  belongs to the group of plants known as
spices. The plant is an erect small plumb with many bar-
nacles usually not more than 1 m high [5]. It is of the fam-
ily Labiatea, genus Ocimum and species gratissimum [6].
The plant is found throughout the tropics and subtropics
and its greatest variability occurs in tropical Africa and
India [7]. In South East Asia, it is cultivated as a home gar-
den crop but it is grown on a commercial scale in Viet-
nam. It is used for a variety of reasons. In culinary, it is
used in salads, soups, pastas, vinegars and jellies in many
parts of the world. The Thai people are popularly known
to use it in food flavouring. In traditional medicine, the
leaves have been used as a general tonic and anti-diarrhea
agent and for the treatment of conjunctivitis by instilling
directly into the eyes; the leaf oil when mixed with alcohol
is applied as a lotion for skin infections, and taken inter-
nally for bronchitis. The dried leaves are snuffed to allevi-
ate headaches and fever among other uses [6]. Although,
conventional antibiotics have been very useful in ortho-
dox medicine, it has been argued by many that its con-
comitant use with herbal extracts is not desirable as one
normally antagonizes the activity of the other. Consider-
ing the fact that Ocimum gratissimum is used in most local
dishes/foods to achieve a variety of purposes, there is need
to ascertain if its extract antagonizes or acts as a synergy
when used together with conventional antibiotics. In
addition, despite the fact that the various extracts of O.
gratissum have been tested in vitro and shown to be active
against some bacteria and fungal isolates [8-11], specific
strain differences supposes that a lot more strains of bac-
teria and fungi across other regions be tested to ascertain
their in vitro activity against this spice and this was one of
the motivations for our study. This study thus investigated
the antibacterial and antifungal properties of O. gratissi-
mum ethanolic leaf extract and its interaction with some
disc antibiotics.
Methods
Identification and preparation of plant material
The plant, Ocimum gratissimum was purchased from Ogige
market in Nsukka, Enugu state, Nigeria. The plant was
identified by A.O Ozioko, a former plant taxonomist at
the herbarium section of the Department of Botany, Uni-
versity of Nigeria, Nsukka, Nigeria. Voucher specimens
were deposited accordingly. The leaves of the plant were
first separated from the stalk, rinsed with water to remove
dirt; air dried at room temperature and ground to fine
powder using an electric blender as previously described
[2]. Extraction was performed by adding a 100 g of the
ground leaf powder in 900 ml of ethanol in a sterile flask,
swirled to ensure effective mixing and stoppered to avoid
loss of volatile liquid at ambient temperature (28 ± 2°C).
The mixture was extracted by agitation on a rotary shaker.
After 48 hrs, the mixture was decanted. The filtrate was
then poured into stainless trays and the extract was
allowed to evaporate to dryness at room temperature (28
± 2°C) for 2-3 days under the microbiological hood set at
appropriate conditions or by using a rotary evaporator in
order to concentrate it. The concentrated extract was then
scooped into a pre-weighed small sterile container and
weighed. The difference between the two weights was
recorded as the percentage yield. The container was then
covered, labeled accordingly and stored in the refrigerator
and was later reconstituted as described previously [2,12]
and used for the tests. The extract yield was 8.5%.
Test isolates
Resistant clinical isolates of P. aeruginosa, P. mirabilis, Sta-
phylococcus aureus,  E. coli, C. albicans and two control
strains E. coli ATCC 11775 and C. albicans ATCC 90028
were used in this study.
Preparation and standardization of inoculum
All isolates were first subcultured to obtain fresh cultures.
The inoculum of each isolate was then prepared according
to the NCCLS approved guideline for bacteria and yeasts
[13] as previously described [2].
Antibiotic Sensitivity discs
Gram negative sensitivity discs manufactured by Potum
laboratories (India) were purchased and used for the
study. The disc contained 10 μg of ciprofloxacin (CPX), 30
10 μg of streptomycin (S), 30 μg of septrin (SXT) and 30
μg of ampicillin (PN). For the antifungal antibiotics discs
of ketoconazole (KET) and nystatin (NYS), Whatmann
No 1 filter paper was cut to give 6 mm diameter paper
discs. The paper discs were sterilized in hot air oven and
later soaked in the prepared desired concentration of the
two antifungal antibiotics used in the study and then
allowed to dry and used for the tests.
Phytochemical analysis of extract
The methods described by Harborne [14] with minor
modifications as described previously [2] were used to test
for the presence of the active ingredients in the test sam-
ple. The phytochemicals tested were tannins, alkaloids,
flavonoids, terpenes, saponins, carbohydrates and cyano-
genetic glycosides.
Determination of the antimicrobial activity of the extract
One gram of the extract was measured into a sterile test
tube and 10 ml of 20% dimethyl sulfur oxide (DMSO)
added to dissolve it. This gave a 100 mg/ml concentration
of the extract and this was diluted in two-folds to obtainBMC Complementary and Alternative Medicine 2009, 9:37 http://www.biomedcentral.com/1472-6882/9/37
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four different dilutions of the extract: 50 mg/ml,25 mg/
ml,12.5 mg/ml and 6.25 mg/ml in addition to the 100
mg/ml concentration. Using a sterile cork borer of diame-
ter 8 mm, 5 wells were dug into the Mueller Hinton agar
medium which was initially flooded with 1 ml of the
standardized inoculum of each test organism and the
excess was drained using a Finn pipette. Each well was
then filled with about 100 μl of the different concentra-
tions of the crude extract. The plates were left for one hour
at room temperature for diffusion to take place and later
incubated for 18-24 hrs at 37°C. The experiment was per-
formed in triplicates and the inhibition zone diameter
was recorded as the average of the three replicates.
Determination of the interaction between the plant 
extract and conventional antibiotics
A solution of the crude extract was diluted in Mueller Hin-
ton agar to concentrations of 25 mg/ml and 6.25 mg/ml.
Twenty five mg/ml was obtained as the sub-inhibitory
concentration for P. aeruginosa, S. aureus and typed strain
and clinical isolates of C. albicans while 6.25 mg/ml was
the sub-inhibitory concentration for P. mirabilis and E. coli
(typed and clinical). Twenty ml of the extract agar mixture
were placed in a Petri dish to form the base extract layer;
2 ml of the molten agar containing 0.2 ml of the test iso-
late was applied as a thin overlay inoculum agar layer and
allowed to solidify. Antibiotic discs were then placed on
the solidified surface. This was done for each of the organ-
ism. For the control, 20 ml of molten agar was poured on
a second Petri dish to produce an extract-free agar layer.
The overlay inoculum agar layer was prepared as
described above. Antibiotic discs were placed ascetically
on the solid surface and this plate was taken as the con-
trol. This was done for each organism. Plates from the
combination and the control were incubated at 37°C for
18 - 24 hours. The experiment was performed in tripli-
cates and the inhibition zone diameter (IZD) was meas-
ured separately and the average of the three replicates were
recorded.
Results
The result of the phytochemical analysis of the O. gratissi-
mum plant extract is shown in Table 1. The extract con-
tained fats and oil in higher quantities (+++), followed
next by reducing sugars and the terpenes (++). Cyanoge-
netic glycosides, saponins, alkaloids and steroidal agly-
cone were next (+) while tannins, anthroquinone and
flavonoid were entirely absent. Table 2 shows the inhibi-
tion zone diameters by the test isolates against different
concentrations of the plant extract. Concentrations of
12.5 and 25 mg/ml inhibited only P. mirabilis. However,
concentrations of 100 and 50 mg/ml showed varying
inhibition zone diameters on all the isolates tested in the
study. Typed and clinical isolates of E. coli could not be
inhibited at any of the concentrations. Table 3 shows the
inhibition zone diameters shown by the conventional
antibiotics on the bacterial and the yeast isolates. Like
expected, there were varying inhibition of all the isolates
used in the study. It also presents the results of the in vitro
interaction studies of the plant extract and the various
antibiotics and summarizes the result of the interaction of
the plant extract and the various antibiotics. Out of the
twenty four different combinations, nine (37.5%) were
synergistic, three (12.5%) were additive, two (8.3%) were
Table 2: The inhibition zone diameters shown by the test isolates against different concentrations of the plant extract
Test isolates Diameter shown by different concentrations of the extract (mm)
Clinical/typed strains 100 mg/ml 50 mg/ml 25 mg/ml 12.5 mg/ml 6.25 mg/ml
S. auerus 19 13.5 - - -
P. aeruginosa 11 9.8 - - -
P. mirabilis 22 21 20 11 -
E. coli ATCC 11775 - --- -
E. coli - --- -
C. albicans ATCC 90028 13 10 - - -
C. albicans 16 13 - - -
D M S O - --- -
Key: -, No inhibition. The values are average figures of three replicates.
Table 1: Results of the phytochemical analysis of Ocimium 
gratissimum leaf extract
Test substances Concentrations
Tannins +
Cyanogenic glycosides +
Anthroquinones -
Saponins +
Terpenes ++
Flavonoids -
Alkaloids +
Reducing sugar ++
Fats and oil +++
Steroidal aglycone +
Key: - Not present; +, present at low concentration; ++, present at 
moderate concentration; +++, present at high concentrationBMC Complementary and Alternative Medicine 2009, 9:37 http://www.biomedcentral.com/1472-6882/9/37
Page 4 of 6
(page number not for citation purposes)
indifferent, seven (29.1%) were antagonistic while three
(122.5%) showed no activity. In general, it implies that
only 29.1% of all the combinations were antagonistic as
compared to 70.9% which were not. The chi square test
was used to calculate the statistical significance and it was
found to be statistically significant (P < 0.05). The mini-
mum inhibitory concentrations (MICs) which are the
least concentrations of the plant extract that inhibited bac-
terial growth were 50 mg/ml for S. aureus, P. aeruginosa, C.
albicans (ATCC 90028), C. albicans and 12.5 mg/ml for P.
mirabilis.
Discussion
In agar diffusion assays, the inhibitory zone diameter pro-
duced is the result of the growth of the test organisms and
the diffusion of the test agents through the agar, both
events occurring simultaneously [15] so it then means
that any factor which affects the rate of microbial growth
or rate of diffusion of the suspected antimicrobial agent
under test, will invariably affect the result. The factors
which were pertinent to the formation of inhibition zone
included the type/nature of the test organisms, the size of
inoculum, the culture media (which should be able to
support the growth of organisms and not interfere with
diffusion or activity of test organisms) and the tempera-
ture of incubation [16]. Secondary metabolites of plants
such as saponins, flavonoids, tannins, carbohydrates, cya-
nogenetic glycosides, reducing sugar and all other active
principles of plants have been shown to be responsible for
the antimicrobial activities shown by these extracts.
[17,2]. However from the phytochemical analysis of this
plant extract, some of these secondary metabolites were
absent (tannins, anthroquinone and flavonoid), some in
low and moderate concentrations and a few in high con-
centration. However, the antimicrobial activities shown
by the extract will likely be due to one or more of the sev-
eral other phytochemical constituents shown to be
present in the extract (Table 1). There was no activity
against E. coli for both the typed culture and the clinical
isolate, as opposed to information in literature [8]. This
may be due to the absence of some secondary metabolites
or the presence of some in low concentration; or it may be
Table 3: Summary of the interaction of the plant extract and the various antibiotics
Test isolates Antibiotic Antibiotic alone (mm) Antibiotic plus plant extract (mm) % change in IZD Interpretation
S. aureus CP 16 16 0 indifference
SX 15 15 0 indifference
PN - - - -
SE 24 22 -8.33 antagonism
P. aeruginosa CP 29 35 20.69 synergism
SX 23 12 -47.83 antagonism
PN - - - -
SE 29 - - -
P. mirabilis CP 15 25 66.67 synergism
SX 24 26 8.33 additive
PN 12 20 66.67 synergism
SE 29 19 -34.48 antagonism
E. coli CP 35 42 20 synergism
ATCC 11775 SX 10 12 20 synergism
PN 16 10 -37.5 antagonism
SE 22 11 -50 antagonism
E. coli CP 39 40 2.56 additive
SX 10 12 20 synergism
PN 8 10 25 synergism
SE 14 11 -21.42 antagonism
C. albicans KE 26 23 -11.54 antagonism
ATCC 90028 NY 38 30 -7.14 antagonism
C. albicans KE 21 27 28.57 synergism
NY 24 32 33.33 synergism
Key: -, No activity; CP, 10 mg of ciprofloxacin; SX, 30 mg of septrin; SE, 30 mg of streptomycin; PN, 30 mg of ampicillin; KE, ketoconazole; NY, 
nystatin.; %, percentage; IZD, inhibition zone diameter.BMC Complementary and Alternative Medicine 2009, 9:37 http://www.biomedcentral.com/1472-6882/9/37
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due to the type of strains used or a slight change in any of
the factors mentioned earlier that are likely to affect rate
of microbial growth or rate of diffusion of the test agent.
A percentage change in the inhibition zone diameter was
used to draw inference on the effects of the interaction on
the test organisms. It has been suggested that for a syner-
gistic effect, the diameter of the zone of inhibition in the
test plate (plate containing the plant extract and the anti-
biotics) should be greater than that in the control plate
(plate containing extract-free base agar layer) by at least
19%. A percentage increase in the inhibition zone diame-
ter that is lower than 19% indicates additivity. Where the
inhibition zone diameters in the test and the control are
equal, the combined antibiotics have indifferent effect
and if the zone diameter in the test is less than the one in
the control, then there is antagonism [18]. It was also
observed that for S. aureus it was only ampicillin that did
not show activity against it. This may be due to the fact
that  S. aureus usually develops resistance to β-lactam
drugs. There was antagonism in inhibitory zone diameter
when streptomycin was combined with the extract. Sep-
trin and ciprofloxacin showed indifferent effects individu-
ally when they were combined with the extract. For P.
mirabilis, all the test antibiotics showed activity. However
when combined with the plant extract, it was observed
that streptomycin showed antagonism. Ciprofloxacin and
ampicillin were synergistic when each was combined with
the extract. However with septrin, there was additivity.
Against P. aeruginosa all test antibiotics showed activity,
but on combining with the plant extract, ciprofloxacin
showed synergism while septrin was antagonistic. Ampi-
cillin and streptomycin did not have any individual activ-
ity when combined with the extract. The antibiotics were
all active against the clinical isolate of E. coli and the typed
culture, when the extract was combined with either cipro-
floxacin or septrin, synergistic interaction was observed.
Moreover, ampicillin and septrin when combined
together with either ciprofloxacin or septrin showed syn-
ergistic interaction. Moreover, ampicilin and streptomy-
cin when combined separately with the extract showed
antagonism against E. coli (ATCC 11755). Against the
clinical isolate of E. coli ciprofloxacin was additive, strep-
tomycin was antagonistic while septrin and ampicillin
were synergistic. Nakamura et al [8] found that the essen-
tial oil of O. gratissimum has antibacterial activity against
Shigella flexineri, E. coli, Klebsiella spp and Proteus mirabilis.
Ketoconazole and nystatin were both active against the
clinical isolate of C. albicans and the type culture. The
effect of interaction between the plant extract and the anti-
biotics was synergistic on C. albicans. Against C. albicans
(ATCC 90028), ketoconazole showed antagonism while
nystatin was additive. In a previous study, using agar dilu-
tion technique, Silva et al [10] demonstrated that O. gratis-
simum  exhibited antifungal activities against the
dermatophytes: M. canis, M. gypseum, T. rubrum and T.
mentagrophytes. Lemos and co-workers [11] also showed
that the ethanolic crude extract and the ethyl acetate, hex-
ane, chloroform, essential oil and eugenol of O. gratissi-
mum  have antifungal activities against C. neoformans.
Generally, it should be remembered that the study is in
vitro, and the likelihood of possibility of change in activ-
ity of microflora of a patient cannot be ruled out as it func-
tions in vivo. Also, the possibility of alteration of the
presence of other exogenous compound and the signifi-
cance of this alteration in modifying drug interaction will
only be determined by detailed pharmacokinetic studies
that relate to the distribution of drugs metabolized by the
microflora and their potentially active metabolites to the
therapeutic response of the patient to the antibiotic.
Conclusively, the result of the interaction of the leaves of
the plant with the antibiotics investigated in this study
was thought to be basically due to the effects of the phy-
tochemical constituents of the plants. Ciprofloxacin
showed the most synergistic effect on the bacterial iso-
lates, followed by septrin and ampicillin. Streptomycin
was antagonistic while ketoconazole and nystatin were
synergistic on only the clinical isolate of C. albicans. The
antibacterial activity shown by the leaf extract O. gratissi-
mum corresponds with the traditional medicinal use of
the plant in some parts of the world [9]. The plant is
known to be used in the treatment of wound infections
for which most of the bacterial species investigated in our
study are known to be the etiological agents.
Conclusion
The study has therefore proven that O. gratissimum has
some antimicrobial effect and can be further investigated
for possible used in formulation of antimicrobial com-
pounds.
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